THE PERCENT OF DOCTOR’S OFFICE VISITS DRIVEN BY FLU LIKE SYMPTOMS LAST WEEK WAS HIGHER THAN THE PEAK OF ANY WINTER FLU SEASON SINCE 2009 TO 2010. SO FAR THIS SEASON, THE CDC ESTIMATES THERE HAVE BEEN ...
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...